ArticleJournal of managed care & specialty pharmacy2023

Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosis.

Landon Z Marshall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.